InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Cherevka Holli, Chief Executive Officer. Director active across 1 companies, notably Ampio Pharmaceuticals, Inc.. Cumulatively, 8 disclosures have been published. The latest transaction was filed on 1 January 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Declarations8 total
€23,75647,200 shares@ €0.503311.43% mcap14.1% of flow
Common Stock
SEC:0001415889-22-000258:0·
€23,75647,200 shares@ €0.503311.43% mcap28.2% of flow
Common Stock
SEC:0001415889-22-000258·
€59,35041,980 shares@ €1.413828.55% mcap35.2% of flow
Common Stock
SEC:0001415889-21-005018:0·
€59,35041,980 shares@ €1.413828.55% mcap70.5% of flow
Common Stock
SEC:0001415889-21-005018·
0500,000 shares0
Common Stock
SEC:0001415889-21-004868·
0500,000 shares0
Common Stock
SEC:0001415889-21-004868:0·
€1,0862,603 shares@ €0.41720.52% mcap0.6% of flow
Common Stock
SEC:0001415889-21-002667:0·
€1,0862,603 shares@ €0.41720.52% mcap1.3% of flow
Common Stock
SEC:0001415889-21-002667·
8 of 8 declarations
About Cherevka Holli
Holli Cherevka is the Chief Operating Officer and President at Ampio Pharmaceuticals, Inc. She leads the company's operations, ensuring that strategic objectives are met. Holli brings extensive experience in the pharmaceutical sector, contributing to innovation and growth at Ampio. Her leadership is essential for the company's future.
